Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 4
2004 2
2005 9
2006 4
2007 7
2008 9
2009 8
2010 9
2011 14
2012 10
2013 9
2014 8
2015 5
2016 10
2017 8
2018 10
2019 4
2020 5
2021 6
2022 5
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Results by year

Filters applied: . Clear all
Page 1
Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing.
Gray HJ, Chatterjee P, Rosati R, Appleyard LR, Durenberger GJ, Diaz RL, Swan HA, Peretti D, Pollastro M, Ainge T, Kapeli K, Pereira S, Margossian AL, Banda K, Goff BA, Swisher EM, Bernard B, Kemp CJ, Grandori C. Gray HJ, et al. Among authors: goff ba. NPJ Precis Oncol. 2023 May 18;7(1):45. doi: 10.1038/s41698-023-00379-8. NPJ Precis Oncol. 2023. PMID: 37202426 Free PMC article.
Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study.
Ghezelayagh TS, Wu ES, Barber EL, Dao MD, Zsiros E, Urban RR, Gray HJ, Goff BA, Shah CA, Neubauer NL, Dai JY, Tanyi JL, Liao JB. Ghezelayagh TS, et al. Among authors: goff ba. Eur J Gynaecol Oncol. 2023 Feb;44(1):17-25. doi: 10.22514/ejgo.2023.002. Epub 2023 Feb 14. Eur J Gynaecol Oncol. 2023. PMID: 36874058 Free PMC article.
Uterine lavage identifies cancer mutations and increased TP53 somatic mutation burden in individuals with ovarian cancer.
Ghezelayagh TS, Kohrn BF, Fredrickson J, Manhardt E, Radke MR, Katz R, Gray HJ, Urban RR, Pennington KP, Liao JB, Doll KM, Simons EJ, Burzawa JK, Goff BA, Speiser P, Swisher EM, Norquist BM, Risques RA. Ghezelayagh TS, et al. Among authors: goff ba. Cancer Res Commun. 2022 Oct;2(10):1282-1292. doi: 10.1158/2767-9764.crc-22-0314. Epub 2022 Oct 27. Cancer Res Commun. 2022. PMID: 36311816 Free PMC article.
Ovarian Cancer Is Not So Silent.
Goff BA. Goff BA. Obstet Gynecol. 2022 Feb 1;139(2):155-156. doi: 10.1097/AOG.0000000000004664. Obstet Gynecol. 2022. PMID: 34991118 No abstract available.
139 results